Journal
JOURNAL OF NEUROIMMUNE PHARMACOLOGY
Volume 16, Issue 3, Pages 634-650Publisher
SPRINGER
DOI: 10.1007/s11481-020-09970-3
Keywords
Opioids; Cerebrospinal fluid; Neuroimmune interface; Neuropathic pain; Chronic pain; Proteomics
Categories
Funding
- College of Anaesthesiologists of Ireland
Ask authors/readers for more resources
The pharmacodynamics of opioids for chronic peripheral neuropathic pain are complex and go beyond classical opioid receptor theory. Proteome analysis of cerebrospinal fluid from patients on opioids showed an increase in proteins related to nervous system development and myeloid leukocyte activation. In addition, patients on opioids had lower expression levels of proteins related to neutrophil mediated immunity, and higher expression levels of neural proteins and receptors compared to the control group.
The pharmacodynamics of opioids for chronic peripheral neuropathic pain are complex and likely extend beyond classical opioid receptor theory. Preclinical evidence of opioid modulation of central immune signalling has not been identified in vivo in humans. Examining the cerebrospinal fluid (CSF) of patients medicated with opioids is required to identify potential pharmacodynamic mechanisms. We compared CSF samples of chronic peripheral neuropathic pain patients receiving opioids (n = 7) versus chronic peripheral neuropathic pain patients not taking opioids (control group, n = 13). Baseline pain scores with demographics were recorded. Proteome analysis was performed using mass spectrometry and secreted neuropeptides were measured by enzyme-linked immunosorbent assay. Based on Gene Ontology analysis, proteins involved in the positive regulation of nervous system development and myeloid leukocyte activation were increased in patients taking opioids versus the control group. The largest decrease in protein expression in patients taking opioids were related to neutrophil mediated immunity. In addition, notably higher expression levels of neural proteins (85%) and receptors (80%) were detected in the opioid group compared to the control group. This study suggests modulation of CNS homeostasis, possibly attributable to opioids, thus highlighting potential mechanisms for the pharmacodynamics of opioids. We also provide new insights into the immunomodulatory functions of opioids in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available